drugset / Trial / NCT00745017

Stress Generation and Recurrent Depression: The Role of Differential Treatment Response

NCT00745017

RandomizedParallel-groupOpen-labelTreatment

Summary

Depression affects over one million people in Canada, resulting in $14.4 billion per year in costs to Canadian society. In order to prevent this often lifelong disorder, it is critically important to identify risk factors for the recurrence of depression. A crucial force in maintaining depression is the generation of stressful life events. That is, individuals who have a history of depression are likely to generate the very events that precipitate future depressive episodes (e.g., relationship break-up, fired from job, conflicts with the law) due to negative personality characteristics and disrupted social support networks resulting from previous episodes. This project is the first to test a model that examines the role of negative personality, low social support, and childhood abuse and neglect as risk factors for the generation of stressful life events that predict future depression. We will test this model in a group of patients meeting formal criteria for depression who will be treated and then followed up for 12 months or until depression recurrence. With this long-term design we will be in a unique position to understand how depression is maintained over time, thus suggesting important treatment strategies to prevent depression recurrence.

Timeline

Start
2001-07
Primary completion
2006-07
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Paroxetine Small molecule 20 mg
Subject Paroxetine Small molecule 40 mg
Subject Sertraline Small molecule 50 mg
Subject Sertraline Small molecule 200 mg
Subject Venlafaxine Small molecule 75 mg
Subject Venlafaxine Small molecule 375 mg